Mission and Vision
Neuropsychiatric and neurodegenerative diseases of adulthood such as depression, schizophrenia, Parkinson’s disease and motor neuron disease are highly disabling diseases that place an immense burden on individuals, their families and society.
The mission of the research training group (RTG) is to further the development of prevention and treatment strategies for these diseases through a deeper understanding of the underlying pathophysiological mechanisms. To fulfill this mission, basic and clinical neuroscientists will combine forces to research the novel key concept that neurodevelopment constitutes a major determinant for the individual’s vulnerability to neuropsychiatric and -degenerative disease in later life. Equally important, the RTG addresses the need to train the next generation of neuroscientists in this important emerging pathophysiological concept.
The members of the RTG envision that the intensive training and research activities will significantly impact on the development of new perspectives for disease prevention and treatment.
Thank you for being part of our first International Symposium!!
We could feature an impressive speaker line up (see poster above) for our Symposium “Neurodevelopment and CNS vulnerability” which took place from 19th – 21st September 2018 in Erlangen. The students and participants experienced a truly inspiring meeting and many new collaborations and ideas were established and exchanged.
We would also like to thank our sponsors Celgene, Novartis, Roche, Janssen, Miltenyi Biotec and Development for the generous support.
Read more and look at our pictures here.
Currently no open positions.